Cerebrolysin asian pacific trial in acute brain injury and neurorecovery: Design and methods

Journal of Neurotrauma

Volumn 32, Issue 8, 2015, Pages 571-580

  Poon, Wai ^a   Vos, Pieter ^b   Muresanu, Dafin ^c   Vester, Johannes ^d   Von Wild, Klaus ^e   Hömberg, Volker ^f   Wang, Ernest ^g   Lee, Tatia M C ^h   Matula, Christian ⁱ  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SLINGELAND HOSPITAL   (Netherlands)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d Department of Biometry and Clinical Research ^*  (Germany)

^e INST OF REPRO MED OF THE UNIV   (Germany)

^f SHR Gesundheitszentrum Bad Wimpfen   (Germany)

^g NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^h UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cerebrolysin; multidimensional; neuroprotection; recovery; traumatic brain injury

Indexed keywords

CEREBROLYSIN; PLACEBO; AMINO ACID; NEUROPROTECTIVE AGENT;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BARTHEL INDEX; CONVALESCENCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FINGER TAPPING TEST; GLASGOW OUTCOME SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTELLIGENCE TEST; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NEUROPROTECTION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROOP TEST; TRAUMATIC BRAIN INJURY; WECHSLER INTELLIGENCE SCALE; BRAIN INJURIES; CHINA; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FAR EAST; METHODOLOGY; MIDDLE AGED; PROCEDURES; SOUTHEAST ASIA;

ADULT; AGED; AMINO ACIDS; ASIA, SOUTHEASTERN; BRAIN INJURIES; CHINA; DOUBLE-BLIND METHOD; FAR EAST; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEUROPROTECTIVE AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; RESEARCH DESIGN;

EID: 84926638769     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3558     Document Type: Article

References (87)

1. Faul, M., Xu, L., Wald, M.M., and Coronado, V.G. (2010). Traumatic Brain Injury in the United States: EmergencyDepartment Visits, Hospitalizations and Deaths 2002-2006. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
2. Prins, M.L. and Giza, C.C. (2012). Repeat traumatic brain injury in the developing brain. Int. J. Dev. Neurosci. 30, 185-190.
3. Langlois, J.A., Rutland-Brown, W., and Wald, M.M. (2006). The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21, 375-378.
4. Finkelstein, E.A., Corso, P.S., and Miller, T.R. (2006). Incidence and Economic Burden of Injuries in the United States. Oxford University Press: New York, New York.
5. Coronado, V.G., McGuire, L.C., Faul, M., Sugerman, D., and Pearson, W. (in press). The epidemiology and prevention of TBI.
6. (2010). Traumatic brain injury: time to end the silence. Lancet Neurol. 9, 331.
7. Bulger, E.M., Nathens, A.B., Rivara, F.P., Moore, M., MacKenzie, E.J., and Jurkovich, G.J. (2002). Management of severe head injury: institutional variations in care and effect on outcome. Crit. Care Med. 30, 1870-1876.
8. Nijboer, J.M., van der Sluis, C.K., van der Naalt, J., Nijsten, M.W., and ten Duis, H.J. (2007). Two cohorts of severely injured trauma patients, nearly two decades apart: unchanged mortality but improved quality of life despite higher age. J. Trauma 63, 670-675.
9. Fakhry, S.M., Trask, A.L., Waller, M.A., and Watts, D.D. (2004). Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges. J.Trauma 56, 492-499.
10. Palmer, S., Bader,M.K.,Qureshi,A., Palmer, J., Shaver, T., Borzatta,M., and Stalcup C. (2001). The impact on outcomes in a community hospital setting of using the AANS traumatic brain injury guidelines. Americans Associations for Neurologic Surgeons. J Trauma 50, 657-664.
11. Stein, S.C., Georgoff, P., Meghan, S., Mizra, K., and Sonnad, S.S. (2010). 150 years of treating severe traumatic brain injury: a systematic review of progress in mortality. J. Neurotrauma 27, 1343-1353.
12. Salazar, A.M., Warden, D.L., Schwab, K., Spector, J., Braverman, S., Walter, J. (2000). Cognitive rehabilitation for traumatic brain injury: a randomized trial. Defense and Veterans Head Injury Program (DVHIP) Study Group. JAMA 283, 3075-3081.
13. Vanderploeg, R.D., Schwab, K., Walker, W.C., Fraser, J.A., Sigford, B.J., Date, E.S., Scott, S.G., Curtiss, G., Salazar, A.M., and Warden, D.L. (2008). Rehabilitation of traumatic brain injury in active duty military personnel and veterans: Defense and Veterans Brain Injury Center randomized controlled trial of two rehabilitation approaches. Arch. Phys. Med. Rehabil. 89, 2227-2238.
14. Mac Donald, C.L., Johnson, A.M., Cooper, D., Nelson, E.C., Werner, N.J., Shimony, J.S., Snyder, A.Z., Raichle, M.E., Witherow, J.R., Fang, R., Flaherty, S.F., and Brody, D.L. (2011). Detection of blastrelated traumatic brain injury in U.S. military personnel. N. Engl. J. Med. 364, 2091-2100.
15. Hoge, C.W., Goldberg, H.M., and Castro, C.A. (2009). Care of war veterans with mild traumatic brain injury-flawed perspectives. N. Engl. J. Med. 360, 1588-1591.
16. Maas, A.I., Harrison-Felix, C.L., Menon, D., Adelson, P.D., Balkin, T., and Bullock, R. (2010). Common data elements for traumatic brain injury: recommendations from the interagency working group on demographics and clinical assessment. Arch. Phys. Med. Rehabil. 91, 1641-1649.
17. Loane, D.J. and Faden, A.I. (2010). Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol. Sci. 31, 596-604.
18. Greve, M.W. and Zink B.J. (2009) Pathophysiology of traumatic brain injury. Mt. Sinai J. Med. 76, 97-104.
19. Muresanu, D.F., Buzoianu, A., Florian, S.I., and von Wild, T. (2012). Towards a roadmap in brain protection and recovery. J. Cell. Mol. Med. 16, 2861-2871.
20. Hetman, M., and Kharebava, G. (2006). Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787-799.
21. Degracia, D.J. (2010). Towards a dynamical network view of brain ischemia and reperfusion. part I: Background and preliminaries. J. Exp. Stroke. Transl. Med. 3, 59-71.
22. Hardingham, G.E., Arnold, F.J., and Bading, H. (2001). A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat. Neurosci. 4, 565-566.
23. Xiong Y., Mahmood A., Chopp M. (2009). Emerging treatments for traumatic brain injury. Expert Opin. Emerg. Drugs 14, 67-84.
24. Hardingham, G.E. (2006). Pro-survival signalling from the NMDA receptor. Biochem Soc Trans 34, 936-938.
25. Ginsberg, M.D. (1997). Injury mechanisms in the ischemic penumbra. Approaches to neuroprotection in acute ischemic stroke. Cerebrovasc. Dis. 7, 7-12.
26. Muresanu, D.F. (2010). Neuromodulation with pleiotropic and multimodal drugs-future approaches to treatment of neurological disorders. Acta Neurochir. Suppl 106, 291-294.
27. Zollikofer, C.P., Ponce De Leon, M.S., Vandermeersch, B., and Leveque, F. (2002). Evidence for interpersonal violence in the St. Cesaire Neanderthal. Proc. Natl. Acad. Sci. U. S. A. 99, 6444-6448.
28. Murray, G.D., Teasdale, G.M., Braakman, R., Cohadon, F., Dearden, M., Iannotti, F., Karimi, A., Lapierre, F., Maas, A., Ohman, J., Persson, L., Servadei, F., Stocchetti, N., Trojanowski, T., and Unterberg, A. (1999). The European Brain Injury Consortium survey of head injuries. Acta Neurochir.141, 223-236.
29. Zafonte, R., Friedewald, W.T., Lee, S.M., Levin, B., az-Arrastia, R., Ansel, B.,Eisenberg,H., Timmons, S.D.,Temkin,N.,Novack, T.,Ricker, J.,Merchant, R., and Jallo, J. (2009). The citicoline brain injury treatment (COBRIT) trial: design and methods. J. Neurotrauma 26, 2207-2216.
30. Riley, C., Hutter-Paier, B.U., Windisch, M., Doppler, E., Moessler, H., and Wronski, R. (2006). A peptide preparation protects cells in organotypic brain slices against death after glutamate intoxication. J Neural Transm. 113, 103-110.
31. Wronski, R., Tompa, P., Hutter-Paier, B., Crailsheim, K., Friedrich, P., and Windisch, M. (2000). Inhibitory effect of a brain derived peptide preparation on the Ca+ +-dependent protease, calpain. J. Neural. Transm. 107, 145-157.
32. Rockenstein, E., Torrance, M., Mante, M., Adame, A., Paulino, A., Rose, J.B., Crews, L., Moessler, H., and Masliah, E. (2006). Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J. Neurosci. Res. 83, 1252-1261.
33. Lombardi, V.R., Windisch, M., Garcia, M., and Cacabelos, R. (1999). Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures. Methods Find. Exp. Clin. Pharmacol. 21, 331-338.
34. Sugita, Y., Kondo, T., Kanazawa, A., Itou, T., and Mizuno, Y. (1993). Protective effects of Cerebrolysin against free radicas: radicals measured before and after ischaemia. No To Shinkei 45, 325-31.
35. Satou, T., Itoh, T., Tamai, Y., Ohde, H., Anderson, A.J., and Hashimoto, S. (2000). Neurotrophic effect of FPF-1070 ( Cerebrolysin) on cultured neurons from chicken embryo dorsal root ganglia, cliary ganglia and sympathetic trunks, 1993. J. Neural. Transm. 107, 1253-1262.
36. Masliah, E., Armasolo, F., Veinbergs, I., Mallory, M., and Samuel, W. (1999). Cerebrolysin ameliorates performance deficits and neuronal damage in apolipoprotein E-deficient mice. Pharmacol. Biochem. Behav. 62, 239-245.
37. Akai, F., Hiruma, S., Sato, T., Iwamoto, N., Fujimoto, M., Ioku, M., and Hashimoto, S. (1992). Neurotrophic factor-like effect of FPF 1070[Cerebrolysin] on septal cholinergic neurons after transections of fimria-fornix in the rat brain. Histol. Histopathol. 7, 213-221.
38. Tatebayashi, Y., Lee, M.H., Li, L., Iqbal, K., and Grundke-Iqbal, I. (2003). The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease. Acta Neuropathol. 105, 225-232.
39. Wilson, B.A. (2008). Neuropsychol. Rehabil. Annu. Rev. Clin. Psychol. 4, 141-162.
40. Maas, A.I.R., Steyerberg, E.W., Marmarou, A., McHugh, G.S., Lingsma, H.F., Butcher, I., Lu, J., Weir, J., Roozenbeek, B., and Murray, G.D. (2010). IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics 7, 127-134.
41. Bagiella, E., Novack, T.A., Ansel, B., Diaz-Arrastia, R., Dikmen, S., Hart, T., and Temkin, N. (2010). Measuring outcome in TBI treatment trials: recommendations from the traumatic Brain injury Clinical Trials Network. J. Head Trauma. Rehabil. 25, 375-382.
42. Margulies, S., and Hicks, R. (2009). Combination therapies for traumatic brain injury: prospective considerations. J. Neurotrauma 26, 925-939.
43. Weir, J., Steyerberg, E.W., Butcher, I., Lu, J., Lingsma, H., McHugh, G., Roozenbeek, B., Maas, A.I., and Murray, G.D. (2012). Does the Extended Glasgow Outcome Scale Add Value to the conventional Glasgow Outcome Scale? J. Neurotrauma 29, 53-58.
44. Murray, G.D., Barer, D., Choi, S., Fernandes, H., Gregson, B., Lees, K.R., Maas, A.I., Marmarou, A., Mendelow, A.D., Steyerberg, E.W., Taylor, G.S., Teasdale, G.M., and Weir, C.J. (2005). Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. J. Neurotrauma 22, 511-517.
45. Roozenbeek, B., Lingsma, H.F., Perel, P., Edwards, P., Roberts, I., Murray, G.D., Maas, A.I., and Steyerberg, E.W. (2011). The added value of ordinal analysis in clinical trials: an example in traumatic brain injury. Crit. Care 15, R127.
46. Gill, M.R., Reiley, D.G., and Green, S.M. (2004). Interrater reliability of Glasgow Coma Scale scores in the emergency department. Ann. Emerg. Med. 43, 215-223.
47. Zuercher, M., Ummenhofer, W., Baltussen, A., and Walder, B. (2009). The use of Glasgow Coma Scale in injury assessment: A critical review. Brain Inj. 23, 371-384.
48. Wilson, J.T., Pettigrew, L.E., and Teasdale, G.M. (1998). Structured interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: guidelines for their use. J. Neurotrauma 15, 573-585.
49. Jennett, B., Snoek, J., Bond, M.R., and Brooks, N. (1981). Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J. Neurol. Neurosurg. Psychiatry 44, 285-293.
50. Mahoney, F., and Barthel, D. (1965). Functional evaluation: the Barthel Index. Maryland State Med. J. 14, 56-61.
51. Schönle, P.W., (1995). The Early Rehabilitation Barthel Index: an early rehabilitation-oriented extension of the Barthel Index. Rehabilitation 34, 69-73.
52. Wechsler, D.W. (1997) Adult Intelligence Scale (WAIS-III). The Psychological Corporation: San Antonio, TX.
53. Donders, J., and Warschausky, S. (1997).WISC-III factor score patterns after traumatic head injury in children. Child Neuropsychol. 3, 71-77.
54. Hawkins, K.A. (1998). Indicators of brain dysfunction derived from graphic representations of the WAIS-III/WMS-III technical manual clinical samples data: A preliminary approach to clinical utility. Clin. Neuropsychol. 12, 535-551.
55. Martin, T.A., Donders, J., and Thompson, E. (2000). Potential of and problems with new measures of psychometric intelligence after traumatic brain injury. Rehabil. Psychol. 45, 402-408.
56. Lee, T., and Chan, C. (2000). Stroop Interference in Chinese and English. J. Clin. Exp. Neuropsychol. 22, 465-471.
57. Reitan, R.M., and Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Neuropsychology Press: Tucson, AZ.
58. Mitrushina, M., Boone, K., and D'Elia, L. (1999). Handbook of Normative Data for Neuropsychological Assessment. Oxford Press: New York, NY.
59. Johnson, S., and Prigatano, G. (2000). Functional MR imaging during finger tapping. BNI Q 16, 37-41.
60. D'Elia, L.F., Satz, P., Uchiyama, C.L., and White, T. (1996). Color Trials Test: Professional Manual. O Taesa: Psychological Assessment Resources.
61. Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975). "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
62. Zigmond, A. and Snaith, R. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 67, 361-370.
63. Bjelland, I., Dahl, A.A., and Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J. Psychosom. Res. 52, 69-77.
64. Colditz, G.A., Miller, J.N., and Mosteller, F. (1988). Measuring gain in the evaluation of medical technology. The probability of a better outcome. Int. J. Technol. Assess. Health Care 4, 637-42.
65. Lachin, J.M. (1992). Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. Stat. Med. 11, 1151-1170.
66. Dimitrenko, A., Tamhane, A.C., and Bretz, F., eds (2009). Multiple Testing Problems in Pharmaceutical Statistics. Chapman and Hall/CRC, United Kingdom.
67. Tang, D., Gnecco, C., and Geller, N. (1989). Design of group sequential clinical trials with multiple endpoints. J. Amer. Statist. Assoc. 84, 776-779.
68. Lachin, J. (1981). Introduction to sample size determination and power analysis for clinical trials. Control Clin. Trials. 2, 93-113.
69. Wei, L.J. and Lachin, J.M. (1984). Two-sample asymptotically distribution-free tests for incomplete multi-variate observations. J. Stat. Assoc. 79, 653-661.
70. Huang, P., Woolson, R., and O'Brien, P. (2008). A rank-based sample size method for multiple outcomes in clinical trials. Statist. Med. 27, 3084-3104.
71. Bretz, F., Koenig, F., Brannath, W., Glimm, E., and Posch, M. (2009). Adaptive designs for confirmatory clinical trials. Stat. Med. 28, 1181-1217.
72. Bauer, P. and Kieser, M. (1999). Combining different phases in the development of medical treatments within a single trial. Stat. Med. 18, 1833-1848.
73. Banik, N., Koehne, K., and Bauer, P. (1996). On the Power of Fisher's combination test for two stage sampling in the presence of nuisance parameters, Biometrics 38, 25-37.
74. Temkin, N., Anderson, G., Winn, R., Ellenbogen, R.G., Britz, G.W., Schuster, J., Lucas, T., Newell, D.W., Mansfield, P.N., Machamer, J.E., Barber, J., and Dikmen, S.S. (2007). Magnesium sulfate for neuroprotection after traumatic brain injury: a randomized controlled trial. Lancet Neurol. 6, 29-38.
75. O'Brien, P.C. (1984). Procedures for comparing samples with multiple endpoints. Biometrics 40, 1079-1087.
76. Lu, M., and Tilley, B. (2001). Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial. Stat. Med. 20, 1891-1901.
77. LaVange, L.M., Durham, T.A., and Koch, G.G. (2005). Randomization-based nonparametric methods for the analysis of multicenter trials. Stat. Methods Med. Res. 14, 281-301.
78. Frick, H. (1997). A note on the bias on O'Brien's OLS test. Biometrical J. 39, 125-128.
79. D'Agostino, R.B., Campbell,M., and Greenhouse, J., (2006). TheMann-Whitney statistic: continuous use and discovery; Special papers for the 25th anniversary of Statistics in Medicine. Stat. Med. 25, 541-542.
80. Maurer, W., Hothorn, L., and Lehmacher, W. (1995). Multiple Comparisons in Drug Clinical Trials and Preclinical Assays: A-Priori Ordered Hypotheses. In: J. Vollmar, (ed). Biometrie in der Chemisch-Pharmazeutischen Industrie. Stuttgart: Fischer Verlag, pps. 3-18.
81. Bauer, P. and Köhne, K. (1994). Evaluation of Experiments with Adaptive Interim Analyses, Biometrics 50, 1029-1041.
82. Maas, A.I.R., Roozenbeek, B., and Manley, G.T. (2010). Clinical trials in traumatic Brain injury: past experience and current developments. Neurotherapeutics 7, 115-126.
83. Lachin, J. (2000). Biostatistical Methods: The Assessment of Relative Risks. Wiley: New York.
84. Hukkelhoven, C., Steyerberg, E.W., Habbema, J.D.F., Farace, E., Marmarou, A., Murray, G.D., Marshall, L.F. and Maas, A.I. (2005). Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J. Neurotrauma 22, 1025-1039.
85. Maas, A.I., Murray, G., Henney, H. III, Kassem, N., Legrand, V., Mangelus, M., Muizelaar, J.P., Stocchetti, N., and Knoller, N. (2006). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomized, placebo-controlled. Clin. Trials Lancet Neurol. 5, 38-45.
86. Hedges, L.V. and Olkin, I. (1985). Statistical Methods for Meta-Analysis. Academic Press, Inc.: San Diego, CA.
87. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Lawrence Erlbeum Associates: Hillsdale, NJ.